Sp1042
STATE OF TEH ART: WHY DOES CHRONIC ABDOMINAL PAIN CONTINUE TO BE SO CHALLENGING
Date
May 9, 2023
Explore related products in the following collection:
Society: AGA
This session will cover a variety of disorders causing chronic abdominal pain which may be very difficult to differentiate. LIVE STREAM SESSION
This session will cover a variety of disorders causing chronic abdominal pain which may be very difficult to differentiate. LIVE STREAM SESSION
Presenter
Tracks
Related Products
INTRODUCTION
SOCIETY: AGA
MONITORING OF CALPROTECTIN IN INFLAMMATORY BOWEL DISEASE USING A SWEAT BASED WEARABLE DEVICE
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
PLACEHOLDER
Perturbations in the gut mucosal immune response contributes to IBD. Non-immune cell popopulations including epithelial and stromal cells also play an important role in intestinal inflammation…
PLACEHOLDER
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
